Torrent Pharmaceuticals Ltd (TORP.NS)
Thu, Feb 8 2018
* DEC QUARTER CONSOL NET PROFIT 580 MILLION RUPEES VERSUS PROFIT OF 2.29 BILLION RUPEES LAST YEAR
* SAYS APPROVED ENHANCEMENT OF BORROWING LIMITS TO 150 BILLION RUPEES
* TO CONSIDER RAISING OF FUNDS VIA ISSUE OF SHARES INCLUDING CONVERTIBLE BONDS / DEBENTURES THROUGH QIP OR OTHER MODES
* PLANS FURTHER INVESTMENTS TO EXPAND BIO-PHARM FACILITIES; WILL INCREASE NUMBER OF PRODUCT FILINGS FROM BIO-PHARM Source text - http://bit.ly/2rjIxJS Further company coverage:
* SAYS ISSUES NCDS WORTH 10 BILLION RUPEES Source text: http://bit.ly/2kwxMxc Further company coverage:
* SAYS TORRENT PHARMACEUTICALS LIMITED COMPLETES ACQUISITION OF BRANDED FORMULATION BUSINESS OF UNICHEM LABORATORIES LIMITED Source text: http://bit.ly/2krSQVo Further company coverage:
* SAYS CO ISSUES NCDS WORTH UP TO 5 BILLION RUPEES ON PRIVATE PLACEMENT BASIS Source text: http://bit.ly/2kmOSBc Further company coverage:
Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.
Nov 3 The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday:
Nov 3 Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.